NextFin News - Anthropic is preparing to publicly unveil an initial public offering that could raise as much as SpaceX's record $86.2 billion debut, and possibly more, in the weeks after the Sept. 7 Labor Day holiday - casting a long shadow over a U.S. listing calendar already crowded with companies racing to be seen. The Claude creator, valued at $965 billion after a $65 billion funding round in May, confidentially filed a draft S-1 with the Securities and Exchange Commission on June 1 and is now planning to move its prospectus into the public view, with a potential listing in late September or early October. The question facing the market is not whether investors will buy Anthropic; it is whether there is room left for anyone else.
The Crowd Before the Headliner
The timing is the first pressure point. Anthropic's public prospectus is expected to land just after Labor Day, the traditional restart of the U.S. dealmaking season, when a backlog of issuers that held back through the summer is expected to file and price. For smaller companies, the calculus is unforgiving: go public in the same window as a once-in-a-generation AI debut, or step aside and wait for the market to digest it.
The backdrop is already busy. U.S. companies have raised roughly $160.6 billion in IPO proceeds through mid-August, within striking distance of 2021's full-year record of $175 billion even before Anthropic's own listing is counted. Renaissance Capital data shows 93 IPOs priced in 2026, with proceeds of $144.0 billion, up more than sixfold from a year earlier. The window is open - but a small number of mega-IPOs are pulling a disproportionate share of investor attention and capital toward the top of the calendar.
Anthropic's expected size makes the crowding effect concrete. SpaceX's June listing raised $75 billion at its initial size and $86.2 billion once underwriters exercised their over-allotment option, debuting at a $1.75 trillion valuation - the largest IPO in history by a wide margin, nearly triple Saudi Aramco's $29.4 billion record set in 2019. Anthropic's bankers are modeling a deal that matches or exceeds that, with some investors projecting a valuation above $2 trillion. A raise of that magnitude is not just another entry on the calendar; it is an event that reorders the calendar around itself.
There is evidence of the squeeze already forming. Gravitics Holdings, a space-infrastructure company, filed to raise $125 million in a Nasdaq listing via reverse merger, with an expected trade date in the first week of September - a small deal trying to thread the needle before the AI giants arrive. The contrast is stark: one company raising enough to build private space-station modules with no revenue, another preparing to absorb more capital than any IPO in history.
Why the Calendar, Not the Capital, Is the Constraint
The instinctive read is that a $100 billion IPO will drain the market of cash. That is not the real mechanism. The constraint is attention, not liquidity - and attention is what sets the price.
An IPO prices on the margin. A bookbuild succeeds when the issuer captures the focused demand of the investors most likely to value it, at a moment when competing stories are thin. When a deal the size of Anthropic's enters that window, two things happen. First, the same pool of large institutional investors - the ones who write the biggest checks in any tech IPO - must decide how much of their risk budget to allocate to it. Second, the media and analyst coverage that normally amplifies a smaller deal's story gets redirected toward the headliner.
The result is a form of demand rationing that does not show up as a cash shortfall. A mid-sized issuer pricing alongside Anthropic may still fill its book, but at a lower price, with weaker aftermarket support, or with a syndicate that had to work harder than expected. That is the crowding tax, and it is paid in valuation, not in unraised proceeds.
This is why the post-Labor Day timing matters so much. The period after the holiday is historically one of the heaviest windows of the year - issuers want the fourth quarter to book a listing, and the market expects fresh deals after the summer lull. Anthropic's decision to target that exact window turns the busiest season into a bottleneck. Companies with flexibility face a clear trade-off: front-run the AI debut and price into a thinner calendar, or wait and hope the headliner's success widens the window behind it.
"The wave of mega-IPOs could serve as both a catalyst and a constraint for the broader new issue market. If these transactions price and trade well, they can build investor confidence and support broader issuance, even though they will likely garner significant investor attention and absorb liquidity from the market," said Rachel Gerring, Americas IPO Leader at EY. "For companies in the IPO pipeline, readiness and flexibility will be critical - whether that means launching ahead of larger deals or waiting for the market to digest them."
The mechanism has a second channel: index and positioning effects. A $2 trillion IPO does not land in an empty market. It lands in a market where mega-cap technology already dominates benchmark weights and where passive ownership is high. New issuance of that scale must be absorbed either by fresh cash or by selling existing holdings - and when the new issue overlaps with themes investors already own heavily, the "making room" process can add to volatility in the very stocks that define the index.
The Structural Shift Beneath the Calendar Crunch
It would be a mistake to read this as a simple cyclical squeeze - a busy quarter that will clear once the deals are done. The deeper story is structural: the AI capital cycle has permanently reset what a public market debut can be.
Consider the anchor points. Before 2019, the largest IPO in history was Saudi Aramco at $29.4 billion. That record stood for seven years. In June 2026, SpaceX raised nearly three times that amount. Now Anthropic is preparing to match or beat it - and OpenAI, valued at $852 billion after raising $122 billion in March, is widely expected to follow. Within a single year, the ceiling on IPO size has moved from the tens of billions to the high tens of billions, and the valuation anchor for a frontier technology company has moved from hundreds of billions to above a trillion dollars.
This is not a cyclical fluctuation that will revert when sentiment cools. It rests on a durable change in the underlying economics: Anthropic's annualized revenue run rate reached $65 billion at the end of July, up from $47 billion in May and just $9 billion at the end of 2025 - a sevenfold increase in under two years. At a $965 billion private valuation, that implies a multiple of roughly 15 times run-rate revenue, aggressive by historical standards but within the norms investors have accepted for frontier AI. If the company prices near $2 trillion, it would be trading at roughly 17 to 20 times a run rate that investors expect to reach $100 billion to $120 billion by year-end.
The multiple is the point. A cyclical IPO boom is driven by generous pricing of ordinary businesses. This cycle is driven by genuinely transformed revenue trajectories - revenue growing fast enough that today's aggressive multiple compresses into tomorrow's reasonable one, provided the growth holds. That is why the crowding is structural rather than temporary: every AI company now measures itself against a trillion-dollar public benchmark, and every issuer in adjacent sectors must decide whether to ride the same valuation wave or accept a discount to it.
There is also a first-mover template effect. Anthropic filed confidentially before OpenAI, giving it the option to set the disclosure template for how a frontier AI lab reports in public markets - on revenue recognition for model usage, on compute-capex intensity, on safety spending, and on the concentration of cloud infrastructure suppliers. The company that lists first writes the playbook that the second must at least explain its deviation from. That is a durable advantage, and it is one reason both companies have an incentive to move before the other, even at the cost of a crowded window.
The Counter-Case: A Wide Window, Not a Closed One
The strongest argument against the crowding thesis is that the market has far more capacity than the calendar suggests. IPO proceeds in 2026 are already running at a record pace, up more than 600 percent year over year, and demand for AI exposure remains insatiable. From this view, Anthropic's debut would not crowd out other issuers - it would validate the sector and widen the window for everything behind it, exactly as SpaceX's successful listing did in June.
There is real evidence for this. The Renaissance IPO ETF is up double digits year to date, and aftermarket performance for the 2026 class has been strong enough to keep the pipeline filling. If Anthropic prices well and trades up, the signal to the market is that investors will absorb even the largest deals - a green light, not a red one. EY's framing of mega-IPOs as "both a catalyst and a constraint" captures this duality: the same deal that absorbs attention can also rebuild the confidence that keeps the window open.
This counter-case has one condition attached, and it is the condition that decides the argument: the aftermarket. Crowding becomes crisis only if the headliner disappoints. A well-received Anthropic debut would pull the whole calendar forward; a weak one would slam the window shut for everyone, because it would tell investors that even the best asset in the market cannot command its price. The risk is asymmetric, and it is concentrated in the issuers least able to move their timing.
So the falsifying signal is specific: if Anthropic prices at or above its expected range in late September or October, trades up in its first week, and no scheduled issuer postpones or withdraws because of it, the crowding thesis is wrong - the window was wide enough all along. If instead even one mid-sized deal steps aside, or Anthropic's aftermarket stumbles, the constraint is real and the issuers still waiting in line will have paid for it.
What Comes Next
The immediate catalyst is the public unveiling of Anthropic's prospectus, expected after Labor Day. That document will put hard numbers to the story - audited losses, compute-capex intensity, customer concentration, and the risk factors the company must disclose. One item is already flagged: public backlash against AI and data centers is expected to be listed as a risk factor, reflecting a Gallup survey that found seven in 10 Americans oppose building AI data centers in their local area. For a company whose growth depends on building more compute, that is not a footnote; it is a constraint on the growth trajectory that justifies the valuation.
Split by time horizon, the picture diverges. In the short term - the weeks around Labor Day - the risk is calendar congestion: a backlog of filings competing for a finite share of investor attention, with pricing power concentrated in the largest issuer. In the medium term - the fourth quarter and into early 2027 - the outcome depends on aftermarket performance: a strong Anthropic debut keeps the window open for OpenAI and the rest of the pipeline; a weak one closes it. In the long term, the structural shift is already locked in regardless of timing: public markets now have a trillion-dollar valuation anchor for AI, and that anchor will shape issuance for years.
Three scenarios frame the path. The base case: Anthropic unveils its prospectus in September, prices in October near a $1.5 trillion to $2 trillion valuation, raises $90 billion to $100 billion, and trades modestly higher - a success that validates the window but leaves smaller issuers to price around it. The upside case: the deal prices above range and rips on day one, pulling forward OpenAI's timeline and triggering a rush of AI-adjacent listings that stretches the calendar into 2027. The downside case: the prospectus reveals heavier losses or slower margin progress than expected, the stock stumbles, and issuers that planned to follow delay into 2027 - leaving the post-Labor Day window crowded with deals that never launch.
The issuers to watch are the ones with the least flexibility: mid-sized technology and AI-infrastructure companies that filed in August and planned to price in September, and any company whose story overlaps with Anthropic's enough to be compared against it directly. Their pricing decisions in the weeks after Labor Day will reveal whether the market is absorbing the supply or rationing it.
Anthropic's IPO was always going to be a landmark. What the crowded calendar reveals is that its real test is not whether the company can raise the money - it is whether the public market can absorb a deal this large without leaving the rest of the line behind. The answer will be written not in Anthropic's prospectus, but in the deals that price around it.
Explore more exclusive insights at nextfin.ai.
